Metabolic and endocrine factors in mild cognitive impairment

Ageing Research Reviews

Volumn 9, Issue 3, 2010, Pages 280-288

  Etgen, Thorleif ^a,b   Bickel, Horst ^a   Förstl, Hans ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Traunstein   (Germany)

Author keywords

Cognitive impairment; Dementia; Etiology; Prevention; Risk factors

Indexed keywords

CHOLINESTERASE INHIBITOR; CYANOCOBALAMIN; ESTROGEN; FOLIC ACID; GESTAGEN; PLACEBO; PYRIDOXINE; TESTOSTERONE; VITAMIN B GROUP;

ALZHEIMER DISEASE; ANDROGEN DEFICIENCY; ANTIINFLAMMATORY ACTIVITY; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; FOLIC ACID DEFICIENCY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTHYROIDISM; HYPOTHYROIDISM; INFLAMMATION; MENOPAUSAL SYNDROME; MILD COGNITIVE IMPAIRMENT; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; THYROID DISEASE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGING; ANIMALS; COGNITION DISORDERS; HORMONES; HUMANS; RISK FACTORS;

EID: 77952548408     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2010.01.003     Document Type: Review

References (103)

1. Aghini-Lombardi F., Antonangeli L., Martino E., Vitti P., Maccherini D., Leoli F., Rago T., Grasso L., Valeriano R., Balestrieri A., and Pinchera A. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J. Clin. Endocrinol. Metab. 84 (1999) 561-566
2. Aisen P.S., Schneider L.S., Sano M., Diaz-Arrastia R., van Dyck C.H., Weiner M.F., Bottiglieri T., Jin S., Stokes K.T., Thomas R.G., and Thal L.J. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300 (2008) 1774-1783
3. Ances B.M., and Ellis R.J. Dementia and neurocognitive disorders due to HIV-1 infection. Semin. Neurol. 27 (2007) 86-92
4. Annweiler C., Schott A.M., Allali G., Bridenbaugh S.A., Kressig R.W., Allain P., Herrmann F.R., and Beauchet O. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74 (2010) 27-32
5. Azad N., Pitale S., Barnes W.E., and Friedman N. Testosterone treatment enhances regional brain perfusion in hypogonadal men. J. Clin. Endocrinol. Metab. 88 (2003) 3064-3068
6. Beauchet O. Testosterone and cognitive function: current clinical evidence of a relationship. Eur. J. Endocrinol. 155 (2006) 773-781
7. Beer T.M., Bland L.B., Bussiere J.R., Neiss M.B., Wersinger E.M., Garzotto M., Ryan C.W., and Janowsky J.S. Testosterone loss and estradiol administration modify memory in men. J. Urol. 175 (2006) 130-135
8. Biasioli S., D'Andrea G., Feriani M., Chiaramonte S., Fabris A., Ronco C., and La Greca G. Uremic encephalopathy: an updating. Clin. Nephrol. 25 (1986) 57-63
9. Bickel H., Gradinger R., Kochs E., and Förstl H. High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study. Dement. Geriatr. Cogn. Disord. 26 (2008) 26-31
10. Bickel H., Mosch E., Seigerschmidt E., Siemen M., and Forstl H. Prevalence and persistence of mild cognitive impairment among elderly patients in general hospitals. Dement Geriatr. Cogn. Disord. 21 (2006) 242-250
11. Bimonte-Nelson H.A., Singleton R.S., Nelson M.E., Eckman C.B., Barber J., Scott T.Y., and Granholm A.C. Testosterone, but not nonaromatizable dihydrotestosterone, improves working memory and alters nerve growth factor levels in aged male rats. Exp. Neurol. 181 (2003) 301-312
12. Blaustein J.D. An estrogen by any other name. Endocrinology 149 (2008) 2697-2698
13. Brady C.B., Gaziano J.M., Cxypoliski R.A., Guarino P.D., Kaufman J.S., Warren S.R., Hartigan P., Goldfarb D.S., and Jamison R.L. Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am. J. Kidney Dis. 54 (2009) 440-449
14. Breteler M.M. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol. Aging 21 (2000) 153-160
15. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., and Porter N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of l-type calcium channel expression in hippocampal neurons. J. Neurosci. 21 (2001) 98-108
16. Buchman A.S., Tanne D., Boyle P.A., Shah R.C., Leurgans S.E., and Bennett D.A. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology 73 (2009) 920-927
17. Canaris G.J., Manowitz N.R., Mayor G., and Ridgway E.C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160 (2000) 526-534
18. Ceresini G., Lauretani F., Maggio M., Ceda G.P., Morganti S., Usberti E., Chezzi C., Valcavi R., Bandinelli S., Guralnik J.M., Cappola A.R., Valenti G., and Ferrucci L. Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J. Am. Geriatr. Soc. 57 (2009) 89-93
19. Chin A.V., Robinson D.J., O'Connell H., Hamilton F., Bruce I., Coen R., Walsh B., Coakley D., Molloy A., Scott J., Lawlor B.A., and Cunningham C.J. Vascular biomarkers of cognitive performance in a community-based elderly population: the Dublin Healthy Ageing study. Age Ageing 37 (2008) 559-564
20. Clarke R., Birks J., Nexo E., Ueland P.M., Schneede J., Scott J., Molloy A., and Evans J.G. Low vitamin B-12 status and risk of cognitive decline in older adults. Am. J. Clin. Nutr. 86 (2007) 1384-1391
21. Clarke R., Refsum H., Birks J., Evans J.G., Johnston C., Sherliker P., Ueland P.M., Schneede J., McPartlin J., Nexo E., and Scott J.M. Screening for vitamin B-12 and folate deficiency in older persons. Am. J. Clin. Nutr. 77 (2003) 1241-1247
22. Cooper D.S. Clinical practice. Subclinical hypothyroidism. N. Engl. J. Med. 345 (2001) 260-265
23. Dong J., Liu W., Wang Y., Hou Y., Xu H., Gong J., Xi Q., and Chen J. Developmental iodine deficiency and hypothyroidism impair spatial memory in adolescent rat hippocampus: involvement of CaMKII, calmodulin and calcineurin. Neurotox. Res. (2009)
24. Eisenstaedt R., Penninx B.W., and Woodman R.C. Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 20 (2006) 213-226
25. Elias M.F., Elias P.K., Seliger S.L., Narsipur S.S., Dore G.A., and Robbins M.A. Chronic kidney disease, creatinine and cognitive functioning. Nephrol. Dial. Transplant. 24 (2009) 2446-2452
26. Etgen T., Bronner M., Sander D., Bickel H., Sander K., and Förstl H. Somatic factors in cognitive impairment. Fortschr. Neurol. Psychiatr. 77 (2009) 72-82
27. Etgen T., Sander D., Chonchol M., Briesenick C., Poppert H., Förstl H., and Bickel H. Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study. Nephrol. Dial. Transplant. 24 (2009) 3144-3150
28. Eyles D.W., Smith S., Kinobe R., Hewison M., and McGrath J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat. 29 (2005) 21-30
29. Förstl H., Bickel H., Frolich L., Gertz H.J., Gutzmann H., Horr R., Pantel J., Schmidt R., Schonknecht P., Ulm K., and Werheid K. MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy. Dtsch. Med. Wochenschr. 134 (2009) 39-44
30. Galen Buckwalter J., Crooks V.C., Robins S.B., and Petitti D.B. Hormone use and cognitive performance in women of advanced age. J. Am. Geriatr. Soc. 52 (2004) 182-186
31. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., and Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13 (2002) 100-105
32. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Chertkow H., Cummings J.L., de Leon M., Feldman H., Ganguli M., Hampel H., Scheltens P., Tierney M.C., Whitehouse P., and Winblad B. Mild cognitive impairment. Lancet 367 (2006) 1262-1270
33. Goodman Y., Bruce A.J., Cheng B., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66 (1996) 1836-1844
34. Gould E., Allan M.D., and McEwen B.S. Dendritic spine density of adult hippocampal pyramidal cells is sensitive to thyroid hormone. Brain Res. 525 (1990) 327-329
35. Green H.J., Pakenham K.I., Headley B.C., Yaxley J., Nicol D.L., Mactaggart P.N., Swanson C., Watson R.B., and Gardiner R.A. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int. 90 (2002) 427-432
36. Gussekloo J., van Exel E., de Craen A.J., Meinders A.E., Frolich M., and Westendorp R.G. Thyroid status, disability and cognitive function, and survival in old age. JAMA 292 (2004) 2591-2599
37. Hailpern S.M., Melamed M.L., Cohen H.W., and Hostetter T.H. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J. Am. Soc. Nephrol. 18 (2007) 2205-2213
38. Henderson V.W. Estrogens, episodic memory, and Alzheimer's disease: a critical update. Semin. Reprod. Med. 27 (2009) 283-293
39. Hilsabeck R.C., Hassanein T.I., Carlson M.D., Ziegler E.A., and Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J. Int. Neuropsychol. Soc. 9 (2003) 847-854
40. Hin H., Clarke R., Sherliker P., Atoyebi W., Emmens K., Birks J., Schneede J., Ueland P.M., Nexo E., Scott J., Molloy A., Donaghy M., Frost C., and Evans J.G. Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study. Age Ageing 35 (2006) 416-422
41. Iliescu E.A., Coo H., McMurray M.H., Meers C.L., Quinn M.M., Singer M.A., and Hopman W.M. Quality of sleep and health-related quality of life in haemodialysis patients. Nephrol. Dial. Transplant. 18 (2003) 126-132
42. Janowsky J.S. Thinking with your gonads: testosterone and cognition. Trends Cogn. Sci. 10 (2006) 77-82
43. Jorde R., Waterloo K., Saleh F., Haug E., and Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J. Neurol. 253 (2006) 464-470
44. Kalmijn S., Mehta K.M., Pols H.A., Hofman A., Drexhage H.A., and Breteler M.M. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin. Endocrinol. (Oxf.) 53 (2000) 733-737
45. Kampen D.L., and Sherwin B.B. Estrogen use and verbal memory in healthy postmenopausal women. Obstet. Gynecol. 83 (1994) 979-983
46. Khatri M., Nickolas T., Moon Y.P., Paik M.C., Rundek T., Elkind M.S., Sacco R.L., and Wright C.B. CKD associates with cognitive decline. J. Am. Soc. Nephrol. 20 (2009) 2427-2432
47. Kipen E., Helme R.D., Wark J.D., and Flicker L. Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J. Am. Geriatr. Soc. 43 (1995) 1088-1091
48. Kurella M., Chertow G.M., Fried L.F., Cummings S.R., Harris T., Simonsick E., Satterfield S., Ayonayon H., and Yaffe K. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J. Am. Soc. Nephrol. 16 (2005) 2127-2133
49. Kurella M., Yaffe K., Shlipak M.G., Wenger N.K., and Chertow G.M. Chronic kidney disease and cognitive impairment in menopausal women. Am. J. Kidney Dis. 45 (2005) 66-76
50. Kurella Tamura M., Wadley V., Yaffe K., McClure L.A., Howard G., Go R., Allman R.M., Warnock D.G., and McClellan W. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am. J. Kidney Dis. 52 (2008) 227-234
51. Lamberts S.W., van den Beld A.W., and van der Lely A.J. The endocrinology of aging. Science 278 (1997) 419-424
52. Lee D.M., Tajar A., Ulubaev A., Pendleton N., O'Neill T.W., O'Connor D.B., Bartfai G., Boonen S., Bouillon R., Casanueva F.F., Finn J.D., Forti G., Giwercman A., Han T.S., Huhtaniemi I.T., Kula K., Lean M.E., Punab M., Silman A.J., Vanderschueren D., and Wu F.C. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J. Neurol. Neurosurg. Psychiatry 80 (2009) 722-729
53. Lethaby A., Hogervorst E., Richards M., Yesufu A., and Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst. Rev. (2008) CD003122
54. Llewellyn D.J., Langa K.M., and Lang I.A. Serum 25-hydroxyvitamin d concentration and cognitive impairment. J. Geriatr. Psychiatry Neurol. 22 (2009) 188-195
55. Luck T., Riedel-Heller S.G., Kaduszkiewicz H., Bickel H., Jessen F., Pentzek M., Wiese B., Koelsch H., van den Bussche H., Abholz H.H., Moesch E., Gorfer S., Angermeyer M.C., Maier W., and Weyerer S. Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement. Geriatr. Cogn. Disord. 24 (2007) 307-316
56. Luckhaus C., Mahabadi B., Grass-Kapanke B., Janner M., Willenberg H., Jager M., Supprian T., and Fehsel K. Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J. Neural. Transm. 116 (2009) 905-911
57. Madero M., Gul A., and Sarnak M.J. Cognitive function in chronic kidney disease. Semin. Dial. 21 (2008) 29-37
58. Maki P.M., and Dumas J. Mechanisms of action of estrogen in the brain: Insights from human neuroimaging and psychopharmacologic studies. Semin. Reprod. Med. 27 (2009) 250-259
59. Maki P.M., and Sundermann E. Hormone therapy and cognitive function. Hum. Reprod. Update 15 (2009) 667-681
60. Malouf M., Grimley E.J., and Areosa S.A. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst. Rev. (2003) CD004514
61. Malouf R., and Areosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst. Rev. (2003) CD004326
62. Malouf R., and Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst. Rev. (2008) CD004514
63. McEwen B.S., Alves S.E., Bulloch K., and Weiland N.G. Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol. Bull. 34 (1998) 251-259
64. McGrath J., Scragg R., Chant D., Eyles D., Burne T., and Obradovic D. No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 29 (2007) 49-54
65. Mitchell A.J., and Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 119 (2009) 252-265
66. Mooijaart S.P., Gussekloo J., Frolich M., Jolles J., Stott D.J., Westendorp R.G., and de Craen A.J. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am. J. Clin. Nutr. 82 (2005) 866-871
67. Mulnard R.A., Cotman C.W., Kawas C., van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., and Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283 (2000) 1007-1015
68. Nes M., Sem S.W., Rousseau B., Bjorneboe G.E., Engedal K., Trygg K., and Pedersen J.I. Dietary intakes and nutritional status of old people with dementia living at home in Oslo. Eur. J. Clin. Nutr. 42 (1988) 581-593
69. Nieschlag E., Swerdloff R., Behre H.M., Gooren L.J., Kaufman J.M., Legros J.J., Lunenfeld B., Morley J.E., Schulman C., Wang C., Weidner W., and Wu F.C. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur. Urol. 48 (2005) 1-4
70. Osterweil D., Syndulko K., Cohen S.N., Pettler-Jennings P.D., Hershman J.M., Cummings J.L., Tourtellotte W.W., and Solomon D.H. Cognitive function in non-demented older adults with hypothyroidism. J. Am. Geriatr. Soc. 40 (1992) 325-335
71. Oudshoorn C., Mattace-Raso F.U., van der Velde N., Colin E.M., and van der Cammen T.J. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 25 (2008) 539-543
72. Panza F., D'Introno A., Colacicco A.M., Capurso C., Del Parigi A., Caselli R.J., Pilotto A., Argentieri G., Scapicchio P.L., Scafato E., Capurso A., and Solfrizzi V. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am. J. Geriatr. Psychiatry 13 (2005) 633-644
73. Park Y.J., Lee E.J., Lee Y.J., Choi S.H., Park J.H., Lee S.B., Lim S., Lee W.W., Jang H.C., Cho B.Y., Woo J.I., and Kim K.W. Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch. Gerontol. Geriatr. (2009)
74. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., and Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58 (2001) 1985-1992
75. Quadri P., Fragiacomo C., Pezzati R., Zanda E., Tettamanti M., and Lucca U. Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin. Chem. Lab. Med. 43 (2005) 1096-1100
76. Reitz C., Tang M.X., Miller J., Green R., and Luchsinger J.A. Plasma homocysteine and risk of mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 27 (2009) 11-17
77. Riggs K.M., Spiro III A., Tucker K., and Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr. 63 (1996) 306-314
78. Roberts L.M., Pattison H., Roalfe A., Franklyn J., Wilson S., Hobbs F.D., and Parle J.V. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction?. Ann. Intern. Med. 145 (2006) 573-581
79. Sato Y., Honda Y., Hayashida N., Iwamoto J., Kanoko T., and Satoh K. Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch. Phys. Med. Rehabil. 86 (2005) 576-581
80. Schmidt R., Fazekas F., Reinhart B., Kapeller P., Fazekas G., Offenbacher H., Eber B., Schumacher M., and Freidl W. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J. Am. Geriatr. Soc. 44 (1996) 1307-1313
81. Seal E.C., Metz J., Flicker L., and Melny J. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J. Am. Geriatr. Soc. 50 (2002) 146-151
82. Seliger S.L., and Sarnak M.J. Subclinical vascular disease of the brain in dialysis patients. Am. J. Kidney Dis. 50 (2007) 8-10
83. Seliger S.L., Siscovick D.S., Stehman-Breen C.O., Gillen D.L., Fitzpatrick A., Bleyer A., and Kuller L.H. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J. Am. Soc. Nephrol. 15 (2004) 1904-1911
84. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., and Coker L.H. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2947-2958
85. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones III B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., and Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
86. Slinin Y., Paudel M.L., Ishani A., Taylor B.C., Yaffe K., Murray A.M., Fink H.A., Orwoll E.S., Cummings S.R., Barrett-Connor E., Jassal S., and Ensrud K.E. Kidney function and cognitive performance and decline in older men. J. Am. Geriatr. Soc. 56 (2008) 2082-2088
87. Slinin Y., Paudel M.L., Taylor B.C., Fink H.A., Ishani A., Canales M.T., Yaffe K., Barrett-Connor E., Orwoll E.S., Shikany J.M., Leblanc E.S., Cauley J.A., and Ensrud K.E. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 74 (2010) 33-41
88. Smogorzewski M.J. Central nervous dysfunction in uremia. Am J. Kidney Dis. 38 (2001) S122-S128
89. Stivelman J.C. Benefits of anaemia treatment on cognitive function. Nephrol. Dial. Transplant. 15 Suppl. 3 (2000) 29-35
90. Tierney M.C., Oh P., Moineddin R., Greenblatt E.M., Snow W.G., Fisher R.H., Iazzetta J., Hyslop P.S., and MacLusky N.J. A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women. Psychoneuroendocrinology 34 (2009) 1065-1074
91. Tirassa P., Thiblin I., Agren G., Vigneti E., Aloe L., and Stenfors C. High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J. Neurosci. Res. 47 (1997) 198-207
92. Troen A.M., Shea-Budgell M., Shukitt-Hale B., Smith D.E., Selhub J., and Rosenberg I.H. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 12474-12479
93. Tucker K.L., Qiao N., Scott T., Rosenberg I., and Spiro III A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am. J. Clin. Nutr. 82 (2005) 627-635
94. van der Wielen R.P., Lowik M.R., van den Berg H., de Groot L.C., Haller J., Moreiras O., and van Staveren W.A. Serum vitamin D concentrations among elderly people in Europe. Lancet 346 (1995) 207-210
95. van Uffelen J.G., Chinapaw M.J., van Mechelen W., and Hopman-Rock M. Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. Br. J. Sports Med. 42 (2008) 344-351
96. Vidal J.S., Dufouil C., Ducros V., and Tzourio C. Homocysteine, folate and cognition in a large community-based sample of elderly people-the 3C Dijon Study. Neuroepidemiology 30 (2008) 207-214
97. Volpato S., Guralnik J.M., Fried L.P., Remaley A.T., Cappola A.R., and Launer L.J. Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58 (2002) 1055-1061
98. Wagner C.K. Progesterone receptors and neural development: a gap between bench and bedside?. Endocrinology 149 (2008) 2743-2749
99. Warren M.F., Serby M.J., and Roane D.M. The effects of testosterone on cognition in elderly men: a review. CNS Spectr. 13 (2008) 887-897
100. Wilkins C.H., Sheline Y.I., Roe C.M., Birge S.J., and Morris J.C. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am. J. Geriatr. Psychiatry 14 (2006) 1032-1040
101. Yaffe K., Grady D., Pressman A., and Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J. Am. Geriatr. Soc. 46 (1998) 816-821
102. Zhang C.E., Wei W., Liu Y.H., Peng J.H., Tian Q., Liu G.P., Zhang Y., and Wang J.Z. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol. 174 (2009) 1481-1491
103. Zitzmann M., Weckesser M., Schober O., and Nieschlag E. Changes in cerebral glucose metabolism and visuospatial capability in hypogonadal males under testosterone substitution therapy. Exp. Clin. Endocrinol. Diabetes 109 (2001) 302-304